NCT01430403.
Trial name or title | Preventative omalizumab or step‐up therapy for severe fall exacerbations (PROSE) |
Methods | Randomised, double‐blind, parallel‐group study |
Participants | Children with asthma six to 17 years |
Interventions | Three arms: omalizumab, fluticasone and placebo |
Outcomes | Exacerbation requiring systemic corticosteroid therapy or hospitalisation |
Starting date | September 2011 |
Contact information | http://clinicaltrials.gov/ct2/show/NCT01430403 |
Notes |